acidity of shed blood; and that fibrin can be converted back to fibrinogen by dissolving it in alkali. His theory is particularly interesting in view of the fact that Anson and Mirsky 1 have recently succeeded in converting heat-denatured serum albumin back to the native protein by simple solution in acid and careful neutralization. However, Hekma's views have failed of general acceptance. As Barkan and Gaspar showed, an alkaline solution of fibrin is not a solution of fibrinogen, for the former cannot be coagulated afresh by the addition of thrombin. Moreover, the coagulation of fibrinogen does not necessarily involve a change in hydrogen ion concentration (Eagle and Baumberger).
Stuber and his coworkers have published an extensive series of papers, in the earliest of which he claimed that thrombin caused coagulation by removing water from fibrinogen, thereby converting it to a dehydrated insoluble form, fibrin. Subsequently, however, he has apparently discarded the classical theories and reactants as artifacts, and has introduced the wholly new idea that coagulation is caused by glycolysis, a concept which has not been verified. As Hartmann and Kfihnau showed, plasma dialyzed free of glucose clots just as readily as normal plasma upon the addition of the necessary electrolytes, and normal plasma may coagulate without any demonstrable glycolysis. Another concomitant of coagulation in the Stuber scheme is an increase in the pH of blood or a fibrinogen solution. Hirsch has reported a decrease in thepH of blood during coagulation; while Eagle and Baumberger have been unable to demonstrate any significant change during the coagulation of fibrinogen by thrombin.
It would therefore seem that we must revert to the classical theories outlined in Table I as the most promising line of attack on the general problem. If-we disregard nosological differences, and seek the basic observations concerning which most of the classical theories are in essential agreement, we find that they all reduce to the following broad formulation: (1) an unidentified substance present in cell-free citrated, oxalated, or untreated plasma (prothrombin); (2) an unidentified substance present primarily in the blood platelets; (3) calcium; and (4) fibrinogen, interact to form an active coagulant, thrombin, and fibrin.
Concerning the details of the reaction, however, we find conflicting views in the literature. This and the following paper represent, first, a reinvestigation of some of the controversial aspects of the coagulation phenomenon, and second, further studies of the mechanism of the reaction.
I The bibliography follows the second paper of this series, page 553. 
8
Methods and Materials
1.
Fibrinogen.--Fibrinogen was prepared from citrated (0.5 per cent) horse, rabbit, dog, or human plasma by four precipitations with 1.2 volumes of saturated NaC1. It was sometimes necessary to add a trace of oxalate or citrate to the saturated salt, as otherwise traces of Ca in the salt caused a part of the fibrinogen to coagulate upon redissolving the precipitate. A trace of sodium bicarbonate was added to the salt solution to keep the reaction weakly alkaline (pH 7.5-8). After each precipitation, the fibrinogen was collected by filtration (usually overnight in the icebox), redissolved in a minimum volume of 0.85 per cent NaC1, usually 1/2 -1/4 that of the previous solution, and reprecipitated. The final solution failed to clot upon the addition of CaCl2, due to the progressive removal of prothrombin and its progressive deterioration in the course of the precipitations, Most of the fibrinogen used in the following experiments was prepared from horse plasma obtained from the Massachusetts State Antitoxin Laboratory, whose courtesy and generosity it is a pleasure to acknowledge.
Prothrombin and
Thrombin.--Various methods have been devised for the preparation of these two reagents. For the former, Howell (1914) and Cekada precipitated plasma with acetone, dried with ether, and extracted the precipitate with slightly alkalinized water. Gratia has inoculated oxalated plasma with staphylococci, the fibrinogen coagulating and leaving the prothrombin in solution.
In preparing thrombin, both the serum and the clot (Herzfeld and Klinger) have been used. In our hands these methods have proved cumbersome or unreliable; and the presence of antithrombin has proved an undesirable complication in using serum as thrombin. Fortunately, a simple method was found 2 which consistently yielded highly active preparations of prothrombin and thrombin within 1 hour after obtaining the plasma. Fresh citrated or oxalated plasma, preferably the former, was diluted with 10 to 15 volumes of cold water, and CO~ gas bubbled through for about 5 minutes. A precipitate formed consisting of plasma euglobulin, a portion of the fibrinogen, and a large part of the thrombin precursor, prothrombin (of. page 538).
The mixture was centrifuged, the supernatant fluid discarded, and the precipitate redissolved in 0.85 per cent salt solution (same volume as the original pla.~rna used). The opalescent solution was brought to approximately pH 7.0, as by the addition of a trace of sodium carbonate, sodium bicarbonate, or very dilute (0.01 N) NaOH. a By this simple procedure prothrombin was obtained free from serum albumin and free from thrombin-inhibitor (antithrombin). If desired, the fibrinogen was removed by heating carefully at 56°C. for 3 to 6 minutes, a procedure which caused 2 We have since learned that a similar method was used by Mellanby, who diluted bird plasma with water and acidified with dilute acetic acid, and by Fuchs (1929 b).
a Phosphate buffer (1/20 volume of M/15 phosphate at pH 8.0) is not as sarisfactory, due to the formation of a precipitate upon the addition of calcium salts. no significant destruction of the prothrombin. The coagulated protein was then removed by centrifuging or by filtration through a small coarse filter paper.
To obtain thrombin, one need only add to the prothrombin solution 1/20 its volume of 0.1 ~ CaCh (1.1 per cent). If the prothrombin had been prepared from untreated plasma, and the fibrinogen had not been removed, the solution dotted in 3 to 15 m~nutes, whereupon it was broken up thoroughly with a glass rod, and filtered through a very small coarse filter paper. The filtrate was a highly active thrombin. If the fibrinogen had been removed by heating the prothrombin solution at 56°C. for about 4 minutes, no clot formed, and the solution was ready to use as thrombin in 15 minutes after the addition of the calcium salt.
The thrombin solution remained serviceable for 1 to 6 days if kept in the ice box, gradually decreasing in activity.
3. Cepkalin.--Cephalin was obtained from pig brains by drying the tissue with acetone, extracting with ether for 3 days, evaporating the ether extract to dryness, and removing the acetone-soluble fraction. The residue was taken up in ether as a I or 10 per cent solution, and 0.1 cc. thoroughly shaken in 10 cc. of salt solution to form a 0.01-0.1 per ceDt suspension. Although the lipoid is referred to as cephalin in the text, it was obviously a crude mixture, containing eephalin, lecithin, and probably other lipoids.
Platelet Suspension and Platelet-Free Plasma.--Platelet-free horse plasma
was prepared by centrifuging citrated plasma for two periods of 1 hour each at 3000 R.P.~. The clear plasma was then passed through a Berkefeld filter. If an adequate amount of CaCI~ is added to such plasma immediately after filtration, it clots very slowly. After 1 hour, however, the plasma becomes completely noneoagnlable by Ca unless platelets or cephalin are also added.
The sediment of platelets obtained upon centrifuging the citrated plasma was washed twice in a volume of salt solution corresponding to the original plasma volume, and resuspended in 1/50 the original volume, making a platelet suspension 50 times as concentrated as the original plasma. That such a suspension has not lost its coagulating properties by the manipulation involved in the repeated centrifuging was shown by the fact that the coagulation time of the platelet-free plasma was restored to its original value by the addition of 1/50 volume of the concentrated platelet suspension (cf. page 541).
5. Quantitative Measurement.--One of the chief handicaps to the study of coagulation has been the use of qualitative instead of quantitative technique. With this in mind, the following quantitative procedure was developed, which, admittedly inexact, has nevertheless proved of great value. Suppose it is necessary to compare the thrombin content of a solution before and after a certain physical or chemical manipulation. Keeping all external factors such as temperature, volume, pH, salt concentration, etc., fixed, and using a constant quantity of all reagents except thrombiu, one measures the coagulation time in each of a series of tubes containing increasing quantities of thrombin. Given this series as a base line, the coagulation time of the unknown solution is then determined under exactly the same conditions, and the thrombin content obtained at once by interpolation (Table II) . The same general method is applicable to every factor entering into coagulation, and is used throughout this and the following paper. The coagulation time is determined by inverting the tube at intervals, gelation sufificient to prevent the contents from pouring being the criterion of coagulation. Care must be taken not to shake the contents, for coagulation is thereby accelerated.
Is Thrombin the Cause or Product of Coagulation?
It has been generally believed (Morawitz, Howell (1916 , 1925 , Border (1920a, b)) that coagulation involves two entirely distinct processes: the first is the complicated series of reactions culminating in the liberation of active thrombin; the second is the interaction of thrombin with fibrinogen to form fibrin. However, Wooldridge (quoted from Morawitz), and more recently Nolf, Stuber, and Pickering (1925, 1928) have maintained that thrombin, like fibrin, is a product of coagulation rather than its cause, and that the reaction cannot be viewed as two consecutive processes.
The prothrombin solution prepared as described on page 534, freed of fibrinogen by heating, made possible a clear-cut test of the two hypotheses. If no thrombin forms unless fibrinogen is also added, then the contention of Wooldridge and Nolf gains credence. On the other hand, if such a fibrinogen-free solution liberates thrombin upon the addition of calcium, and if the thrombin forms in less than the coagulation time of the original solution, this clearly indicates that thrombin is not a product of coagulation, but its cause. As shown in Protocol 1 the latter is correct. Confirming Bordet (1920a, b) the amount of thrombin formed upon adding CaC12 to a prothrombin solution is practically the same in the presence or absence of fibrinogen. A quantitative study of the velocity of thrombin formation shows that coagulation is coincident with the sudden liberation of large quantities of thrombin, sufficient to cause an almost instantaneous coagulation (< 15 seconds) of the fibrinogen present in the solution. As indicated, between 4 and 8 minutes after adding CaCl~ to the fibrinogen-free prothrombin, there was a sudden liberation of thrombin. If Ca salt was added to the same unheated prothrombin, containing fibrinogen, coagulation occurred in 4t minutes, coincident with the sudden liberation of thrombin; and the concentration of thrombin in the fluid expressed from the clot was either the same or less than that formed in the absence of fibrinogen, clear evidence that thrombin is not a byproduct of coagulation.
As was originally believed by Schmidt in 1876 (quoted from Morawitz), and contrary to the contention of Wooldridge (quoted from Morawitz), Nolf, Stuber, and Picketing (1928) the process of coagulation may therefore be separated into at least two distinct reactions:
Plasma factor -t-platelet factor -b Ca --* thrombin Thrombin + fibrinogen --~ fibrin.
The RSle of the Plasma Factor, Prothrombin, in the Coagulation Process
The term prothrombin (thrombin precursor) was applied to the plasma factor by Schmidt long before the essential r61e zf Ca salts and blood platelets had been discovered. However, the e~periments illustrated in Figs. 1, 2, and 3 Showing that the amount of thrombin formed depends upon the quantity of prothrombin used. 1, 2, 4, and 8 cc. of platelet-free prothrombin solution (page 534) + 1 cc. of a phatelet suspension tenfold concentrated as compared to the original plasma + 1 cc. 0.1 g CaC1, + 0.85 per cent NaC1 to 10 cc. The thrombin formation was foUowed quantitatively by the method of page 534. the plasma constituent seems to be the true thrombin-precursor, merely activated by Ca and platelets to form thrombin. As is shown in the figures, the amount of thrombin ultimately formed from a mixture of these three reagents is independent of the amount of Ca, platelets, or cephalin used, but varies directly with the amount of the plasma factor. The thrombin was measured by the method described on page 535. Although the figures give the results with horse plasma, similar results were obtained with dog, rabbit, and human prothrombin, using either a suspension of cephalin or platelets as the activator. The plasma factor has therefore been correctly termed prothrombin, although its chemical nature, like that of thrombin, remains unknown.
We have been unable to confirm its ready adsorption by colloidal Mg(OH)~ or Cas(PO~)2 as claimed by Fuchs and Hartmann; in our Pen The use of Bordet's term serozyme instead of prothrombin for the plasma factor is to be discouraged, for it implies that the substance is an enzyme, a point of view which is still controversial. The term thrombogen used by Morawitz is as non-committal as the term prothrombin, and therefore equally satisfactory.
The Rale of the Platelet Factor (Cephalln?) in the Formation of Thrombin
The importance of the blood platelets for coagulation is clearly shown by the fact that even partial removal by centrifuging citrated or oxalated blood at high speed tends to retard coagulation upon subsequent recalcification; and as Cramer and Pringle showed, if the platelets are removed completely, as by Berkefeld fltration, coagulation may be completely prevented. If the latter experiment is repeated quantitatively, one obtains results similar to those summarized in Fig. 4 . The addition of platelets to Berkefeld-filtered plasma causes a progressive and striking increase in the velocity of coagulation upon recalcification, from an initial coagulation time of > 3000 minutes to one of 1-3 minutes. Clearly, the often-quoted fact that the blood of patients with purpura hemorrhagica may clot despite platelet counts as low as 20,000 does not disprove their participation in coagulation. In the experiment of Fig. 4 , the original plasma dotted in 14 minutes upon recalcification; complete removal of the platelets by Berkefeld filtration rendered the plasma non-coagulable (cf. page 535); and as little as 1/20 or even 1/50 of the original platelet concentration sufficed to restore its coagulability. Platelet counts of even 10,000 per c.mm. represent a quantity adequate to cause a slow but complete transformation of prothrombin to thrombin and of fibrinogen to fibrin.
The use of the terms thrombokinase and thrombozyme for the platelet factor is to be discouraged, inasmuch as these terms imply that it is an enzyme or a coenzyme facilitating the production of thrombin, a hypothesis for which there is some evidence, but which certainly cannot be regarded as proved.
Howell (1912) and Rumpf have shown that a lipoid present in most animal tissue, which both Howell, and Gratia and Levene have identified as cephalin, was an adequate substitute for platelets in ~ the coagulation process. Howell therefore suggested that when platelets disintegrate in shed blood they liberate cephalin, which then participates in coagulation. However, as both Howell and Rumpf have shown, if platelets are extracted with lipoid solvents, only a small fraction (in our hands, less than 10 per cent) of their coagulating activity is recovered in the lipoid solution. Possibly, as Howell has suggested, the active component of platelets is a cephalin-protein complex which is more efficient than the cephalin itself.
I
Numerous workers (Bayne-Jones, Christie, Davies, and Stewart, and Fuchs (1929, 1930 ) view the platelets not only as a source of a cephalin-like substance, but also as a source of prothrombin. This finding, however, we have been unable to confirm. In our hands, horse, rabbit, or dog platelets washed free of plasma do not contain significant or even demonstrable quantities of prothrombin, while M~n.
;00 their coagulating activity as platelets is quantitatively the same as in the original plasma (Protocol 2).
Protocol 2. Showing That Platelets Contain no Demonstrable Quantities of Pro-
thrombin.--A suspension of washed horse platelets in 0.85 per cent NaCI was prepared, 25-fold concentrated with respect to the original plasma (page 535). The coagulation time of a platelet-free horse plasma was restored to normal by the addition of 1/25 volume of this suspension (cf. Fig. 4) , indicating that the eoagulat-ing activity of the platelets had not been impaired by the washing. To 20 cc. of the platdet suspension was added 1 cc. of 0.1 M CaC12 and the thrombin activity of the whole suspension and of the supernatant fluid tested at intervals (2, 4, 8, 16 , 32, and 64 minutes after the addition of the CaCI~). No demonstrable thrombin appeared; while a solution of prothombin prepared from the same platelet-free plasma developed very active thrombin upon the addition of CaC12 and a trace of cephalin.
Suspending the platelets in H20 instead of salt solution for 1 hour prior to the addition of CaCh and NaCI in sufficient quantity to restore isotonicity with blood had no effect on the results; and the use of oxalated instead of citrated blood was likewise ineffective. Qualitatively the same results were obtained with rabbit and dog platelets. In only one instance was prothrombin demonstrated in a horse platelet suspension, after treatment with H,O and CaCI,: and in that case the quantity was less than 1/200 :that present in the platelet-free plasma, suggesting indeed that the prothrombin originated from traces of plasma incompletely removed by washing, rather than the platelets themselves. Platelets, therefore, have not been demonstrated to contribute significant quantities of prothrombin; their effect in coagulation rests upon their eephalin-like activity in accelerating the formation of thrombin.
How platelets (or cephalin) accelerate coagulation has hitherto remained an open question. The use of a quantitative method discloses the fact that they do not affect the total amount of thrombin produced, but act by accelerating the rate of thrombin production (Protocol 3 and Figs. 2 and 3) . The more platelets used, the more rapid is the appearance of thrombin and the subsequent coagulation; but the total amount of thrombin formed if the process is allowed to proceed to equilibrium in the absence of fibrinogen depends solely upon the amount of prothrombin used.
Protocol 3. Showing That Platelets and Cephalin Accelerate Coagulation by
Increasing the Rate of Thrombin Formation, without Affecting the Quantity of Throrabin Produced.--Prothrombin was prepared from platelet-free horse plasma non-coagulable by Ca (page 534), heated to remove fibtinogen (page 534), and 1 ce. was placed in each of a series of tubes. Serially increasing quantities of a concentrated platelet suspension (page 535), or of a cephalin suspension were added, the volume adjusted to 2 cc., and 0.1 cc. of 0.1 M CaCh added to each tube. At various intervals, 0.1 cc. of each solution was withdrawn and quickly added to 1 cc. of horse fibrinogen solution; the velocity of coagulation serving as a quantitative measure of thrombin activity (page 535). In plotting the results in Figs. 2 and 3 , the maximum quantity of thrombin formed has been taken as 100.
Similar results were obtained with rabbit and human plasma prothrombin and platelets.
Whether the platelet factor actually combines with prothrombin to form thrombin must remain an open question. The fact that the total amount of thrombin elaborated depends solely upon the amount of prothrombin used (Fig. 1) and is independent of the amount of platelets used, strongly suggests that the platelets merely catalyze the reaction between prothrombin and Ca, without themselves contributing to the compound formed. A decisive experiment would be the formation of thrombin in the complete absence of platelets or cephalin. If prothrombin is prepared from platelet-free plasma (page 534), and CaCI~ added, thrombin does form very slowly in the complete absence of platelets, (lowest curve of Fig. 3) . However, the possibility cannot be excluded that enough platelets disintegrate in the course of the centrifuging and Berkefeld filtration to explain the observed thrombin-formation. ~ Whatever the mechanism, whether a platelet factor actually combines with prothrombin, or whether it merely accelerates a reaction which proceeds slowly even in its absence, the physiological r61e of the platelets in coagulation lies in the fact that they enormously accelerate the production of thrombin.
No evidence was found for the view that platelets are species-specific in their coagulating activity, that is, react specifically with prothrombin of the same species. Either horse, human, rabbit, or dog platelets will activate prothrombin derived from any of these species. SUMMARY amount and rate of thrombin formation in the first reaction are independent of the presence or absence of fibrinogen. After a variable latent period, thrombin suddenly appears in large quantities, coincident with or immediately preceding the deposition of fibrin if fibrinogen is present.
3. The amount of thrombin formed in a mixture of prothrombin, Ca and platelets is independent of the platelet or Ca concentration, and depends primarily upon the amount of prothrombin used. The platelets (or cephalin) enormously accelerate the transformation of prothrombin to thrombin, and this acceleration seems to be their physiological rS~e in the coagulation process.
4. Contrary to previous reports, platelets have not been demonstrated to contain significant quantities of prothrombin.
5. The available data do not allow any definite decision as to whether the platelet factor actually combines with prothrombin to form thrombin, or merely catalyzes the transformation. The very slow formation of thrombin in the complete absence of platelets may be due to dissolved traces of platelet material released during the physical manipulation of the plasma (centrifuging, Berkefeld filtration).
6. There was no evidence for a species-specific activity of platelets in the transformation of prothrombin to thrombin.
(The bibliography for both papers is given at the end of the second paper (page 553).)
